Phase I, healthy, pharmacokinetics
Showing 1 - 25 of >10,000
Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)
Completed
- Healthy Subject
- CT-P41
- US-licensed Prolia
-
Seongnam, Bundang-gu, Korea, Republic of
- +1 more
Sep 7, 2023
Healthy Volunteers Trial in Beijing (RC1416(SAD), Placebo(SAD))
Recruiting
- Healthy Volunteers
- RC1416(SAD)
- Placebo(SAD)
-
Beijing, Beijing, ChinaChina-japan Friendship Hospital
Sep 27, 2023
Pneumococcal Disease Trial (XJ103 Injection, Placebo)
Not yet recruiting
- Pneumococcal Disease
- XJ103 Injection
- Placebo
- (no location specified)
Sep 6, 2023
Healthy Trial in Shanghai (SR750 tablet, Placebo)
Recruiting
- Healthy
- SR750 tablet
- Placebo
-
Shanghai, ChinaShanghai Clinical Research Center Phase I Clinical Research Unit
Mar 1, 2023
Staphylococcus Aureus Bloodstream Infection Trial (XJ101 for Injection, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bloodstream Infection
- XJ101 for Injection
- Placebo
- (no location specified)
Aug 25, 2023
Healthy Volunteer Trial in Los Angeles (IRL201104, Placebo)
Recruiting
- Healthy Volunteer
- IRL201104
- Placebo
-
Los Angeles, CaliforniaRevolo Phase I site
Jun 19, 2023
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder) Trial in Los Angeles (MBS-COV, Placebo)
Recruiting
- Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)
- MBS-COV
- Placebo
-
Los Angeles, CaliforniaPhase I Unit
Jan 10, 2023
Healthy Volunteers Trial in Nedlands (VG290131)
Recruiting
- Healthy Volunteers
-
Nedlands, Western Australia, AustraliaLinear Clinical Research Ltd
Oct 17, 2023
Non-alcoholic Steatohepatitis Trial (AZD9550, Placebo)
Not yet recruiting
- Non-alcoholic Steatohepatitis
- AZD9550
- Placebo
- (no location specified)
Apr 27, 2023
Pulmonary Arterial Hypertension Trial in Adelaide (L608 Inhalation Solution, Placebo solution)
Not yet recruiting
- Pulmonary Arterial Hypertension
- L608 Inhalation Solution
- Placebo solution
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jul 12, 2023
Biliary Carcinoma Trial in Qingdao (TQB3454 tablets)
Not yet recruiting
- Biliary Carcinoma
- TQB3454 tablets
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Nov 15, 2023
Healthy Participants Trial in Glendale (AZD2389, Placebo)
Not yet recruiting
- Healthy Participants
- AZD2389
- Placebo
-
Glendale, CaliforniaResearch Site
Nov 14, 2023
Healthy Male Trial in Beijing (Envafolimab with new manufacturing process, Envafolimab with old manufacturing process)
Not yet recruiting
- Healthy Male
- Envafolimab with new manufacturing process
- Envafolimab with old manufacturing process
-
Beijing, Beijing, ChinaBeijing Gaobo Boren Hosipital
May 9, 2023
Nonalcoholic Steatohepatitis Trial in Taipei (HUYPS-1 one tablet, HUYPS-1 nine tablets)
Completed
- Nonalcoholic Steatohepatitis
- HUYPS-1 one tablet
- HUYPS-1 nine tablets
-
Taipei, TaiwanTri-Service General Hospital
Aug 1, 2023
Healthy Participants Trial in Sumida-ku (AZD2693, Placebo)
Active, not recruiting
- Healthy Participants
- AZD2693
- Placebo
-
Sumida-ku, JapanResearch Site
Jan 18, 2023
Alzheimer Trial in Beijing (XTR006)
Recruiting
- Alzheimer Disease
- XTR006
-
Beijing, Beijing Shi, ChinaChinese PLA General Hospital
Nov 21, 2023
Elder Trial in Jinan (SIM0417/Ritonavir)
Recruiting
- Elder
-
Jinan, Shandong, ChinaShandong First Medical University
Apr 20, 2023
Hypertension, Dyslipidemias Trial (CKD-348(6), CKD-828, D097, D337)
Not yet recruiting
- Hypertension
- Dyslipidemias
- CKD-348(6)
- CKD-828, D097, D337
- (no location specified)
Oct 29, 2023
Myelofibrosis Trial in Changchun (TQ05105 Tablets)
Completed
- Myelofibrosis
- TQ05105 Tablets
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Aug 1, 2023